Eiichi Nagai

Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.

Kiyoshi Takasuna, Takehiro Hagiwara, Masaaki Hirohashi et al. · PubMed · 1996 · 338 citations

Biochemistry, Gastrointestinal Pharmacology, Intestinal Microflora +14

Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats

Kiyoshi Takasuna, Takehiro Hagiwara, Masaaki Hirohashi et al. · Cancer Chemotherapy and Pharmacology · 1998 · 115 citations

Gastrointestinal Pharmacology, Medicine, Gastroenterology +7

Protective Effects of <i>Kampo</i> Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats

Kiyoshi Takasuna, Yoshio Kasai, Yutaka Kitano et al. · Japanese Journal of Cancer Research · 1995 · 97 citations · Full text

In vitro wear of indirect composite restoratives

Shiro Suzuki, Eiichi Nagai, Yohsuke Taira et al. · Journal of Prosthetic Dentistry · 2002 · 84 citations

Wear Testing, Wear Prevention, Vitro Wear +2

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

Kiyoshi Takasuna, Toshihiko Hagiwara, Kyohei Watanabe et al. · Cancer Chemotherapy and Pharmacology · 2006 · 77 citations

Health Sciences, Gastrointestinal Oncology, Optimal Antidiarrhea Treatment +7